Hepatica v1
Overview
Hepatica v1 is a clinical and surgical decision support tool developed by Perspectum. It utilizes artificial intelligence to provide quantitative measurements and visualizations of liver health from magnetic resonance imaging (MRI) data.
The software is designed to assist clinicians in assessing a patient’s liver health, particularly for pre-surgical planning in liver cancer. It performs AI-driven delineation of the liver and individual Couinaud segments, generating a single report that includes quantitative metrics and images.
Hepatica v1 quantifies liver fibro-inflammation (cT1), fat (PDFF), and volume for both the whole liver and individual Couinaud segments. This information helps clinicians accurately predict future liver remnant (FLR) to inform surgical decision-making, identify patients at risk of poor post-operative outcomes, and potentially reduce post-surgical complication rates and hospital stays.
The tool integrates seamlessly into clinical workflows through a PACS-integrated cloud-based service and provides patient-friendly reports.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-driven delineation of liver and Couinaud segments
- Quantitative metrics for liver fibro-inflammation (cT1), fat (PDFF), and volume
- 3D visualization and quantification of whole liver volume
- Supports identification of patients at risk of poor post-operative outcomes
- Clinically validated metrics for pre-operative liver health assessment
- Patient-friendly reports
- Seamless integration into workflow through a PACS-integrated cloud-based service
- MRI-based, non-invasive, no radiation risk
- Automatic liver segmentation and volumetry
- Supports clinical estimation of Future Liver Remnant (FLR) volume
Use Cases
- Pre-surgical decision making for patients with liver cancer
- Assessment of overall liver health and volume
- Risk stratification for post-operative outcomes in liver resection surgery
- Identifying and characterizing undiagnosed background liver disease
- Monitoring changes in liver health and volume (e.g., after DVE)
- Supporting multidisciplinary teams and tumor boards in treatment planning
What Physicians Need to Know
Hepatica v1 can be a valuable tool for pre-operative assessment in liver cancer patients, offering quantitative insights into liver health and volume. Pay close attention to the AI-driven segmentation and biomarker quantification (cT1 for fibro-inflammation and PDFF for fat) within individual Couinaud segments, as this can inform surgical planning and help predict post-operative risks. Integrating this information into multidisciplinary team discussions can lead to more informed decisions and potentially improved patient outcomes. The non-invasive nature (MRI-based) is also beneficial for patient safety.
Hepatica v1 is designed for seamless integration into existing clinical workflows, delivering patient-friendly reports via a PACS-integrated cloud-based service. This allows for efficient access to quantitative liver health assessments within the established imaging and reporting infrastructure of a healthcare facility.
Details
| Category | Oncology AI, Radiology & Imaging AI, Surgical AI |
| Pricing | Contact vendor for pricing details; service is reimbursed by cms and covered by many commercial payers. |
| Deployment | Cloud-based service, PACS-integrated |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | General Surgery, Oncology, Radiology |
What the Web Says
Hepatica v1 by Perspectum is a post-processing medical device software designed to provide quantified metrics for assessing a patient's liver health. It utilizes MRI data to generate these metrics and is FDA-cleared. The software is part of a suite of AI tools aimed at streamlining liver health assessment in conjunction with other imaging technologies.
Overall: PositiveStrengths
- Provides quantified metrics for liver health assessment
- Utilizes MRI as its modality
- FDA-cleared
- Aids in streamlining liver health assessment
- Supports review of MR data
Limitations
No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.
Based on reviews from: parikhradiology.com, scribd.com, nih.gov
Last updated: 2026-10-31
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Hepatica v1
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Hepatica v1.
No videos found. Search YouTube directly
